|
Michael & Dianne Bienes Comprehensive Cancer Center
Holy Cross Hospital, Ft. Lauderdale, Florida
Saturday, February 7, 2004
The primary purpose of the Update 2004 program jointly hosted by the SynCure Cancer Research Foundation and the Michael and Diane Bienes Cancer Center at Holy Cross Hospital was to provide a substantive educational program on advancements in cancer research and treatment for cancer patients, their friends and family, the health care/support community, and the general public. By all accounts, the symposium was a tremendous success. There were 449 registrants and an audience of approximately 330.
This program was made possible at no cost to the public by the support of our corporate sponsors:
Platinum Sponsor:
AstraZeneca
Gold Sponsor:
Biogen Idec
Silver Sponsors:
Amgen, Bristol-Myers Squibb, Genetech, Eli Lilly & Company, Pfizer, Sanofi-Synthelabo, Wyeth
Bronze Sponsors:
Celgene, Cell Therapeutics, Roche, MedImmune Oncology, Ortho Biotech, Vitas Healthcare
Agenda
| Welcome & Introduction |
Maureen Mann |
Holy Cross Hospital |
|
Michael D. Devine, Ph.D. |
SynCure Cancer Research Foundation |
| Overview of the War on Cancer |
Nadia Ramdin, M.D. |
Holy Cross Hospital |
| Making Informed Decisions About Complementary Medicine |
Anne Washburn, MPH |
National Cancer Institute |
| Advances in Radiation Oncology & Radiology |
Marshal Lieberfarb, M.D. |
Holy Cross Hospital |
| Break |
|
|
| Advances in Immunotherapy |
Martin Gutierrez, M.D. |
National Cancer Institute |
| The Critical Role of Clinical Trials |
Carl Tahn, M.D. |
Holy Cross Hospital |
| Luncheon |
|
|
| New Generation Targeted Drugs |
J. Paul Eder, M.D. |
Harvard/Dana Farber Cancer Institute |
| Question and Answer Panel Discussion |
Moderator, J. Paul Eder, M.D. |
|
|
|
|
Attendees Comments
| 1) |
Miles beyond our expectations! The doctors, the assistants, etc. are most helpful, caring and understanding. |
| 2) |
Very interesting and informative. Since I am unhappy with my oncologist, I will be in-touch with Holy Cross. Very well put together seminar. Hope to see more. |
| 3) |
Good, very organized, nice to have the agenda and know each person would speak 30 minutes. Plus the Q&A. Thank you for sponsoring and funding this conference. |
| 4) |
Extremely informative in many facets of cancer concern. I liked the "depth" of the subject matter - lifted my knowledge base even if I didn't comprehend all of it. Can't beat the PowerPoint presentations. |
| 5) |
I have attended many seminars on Mental Health and was amazed at the knowledge. However, since my breast cancer - there was very little public lectures, etc. This program was wonderfully explicit, knowledgeable and caring. Please keep it up - this wonderful way of teaching and informing us. |
| 6) |
Great educational tool to explain the basics of cancer care. Often the nurse and doctor do not have the time to explain everything. The internet is good but what you presented puts things into perspective and allows the patient the ability to manage their own problem rather than just being told what to do. |
| 7) |
Excellent! Superb! Bravo! For all the great organization. It was a real pleasure to listen and learn a vast field about cancer. I would like to thank everyone (physicians, administration, staff, etc.) for years of wonderful work. |
| 8) |
Kudos!!! I feel that is was excellent. Very informative and well presented. I feel that they tried to present it in "layman's" terms to make it understandable to all. The doctors and speakers were excellent and I felt that they were all compassionate, caring individuals who have my full admiration. The Q&A session was very good. It feels good to know there are MD's who take the time to do something such as this to help the public. It helps to sit and have an intelligent discussion about cancer rather than just having the fear and anxiety about cancer. It makes it seem much more down to earth and not so terrifying. My highest commendations go to presenting such a program to the public. |
Speakers
J. Paul Eder, M.D.
Assistant Professor, Harvard Medical School
Associate Physician, Dana-Farber Cancer Institute
Boston, MA
|
|
Dr. Eder is an academic research oncologist with expertise in clinical trials of new cancer drugs and the biochemical mechanisms of drug resistance. In addition to his appointments at Harvard and Dana-Farber, where he is the Clinical Director of the Experimental Therapeutics Program, he is on the clinical staff at Beth Israel Deaconess Hospital and Brigham and Women's Hospital. Dr. Eder received his MD degree from the Georgetown University School of Medicine. Presently, he is an investigator on two clinical studies sponsored by the National Cancer Institute; one involves the angiogenesis inhibitor angiostatin and the other study targets the development of vaccines for multiple myeloma.
|
Martin Gutierrez, MD
Head, Office of Navy Oncology
National Cancer Institute
Bethesda, MD
|
|
Dr. Gutierrez received his MD from Javeriana University in Bogota Colombia. He has served as chief resident in Medicine at the Boston University Hospital, completed an oncology fellowship in medical oncology at the National Cancer Institute, and received training in hematology at the National Heart Lung and Blood Institute in Bethesda, Maryland. Subsequently, Dr. Gutierrez worked at the Bienes Comprehensive Cancer Center, Holy Cross Hospital as principal investigator and liaison for the "Partnership in Science" Pilot Program, between the National Cancer Institute and Holy Cross Hospital. Presently, his research interest lies in targeted therapies for the treatment of lung cancer and non-Hodgkin's lymphoma.
|
Marshal Evan Lieberfarb, MD, PhD
Physician (Radiation Oncologist)
Bienes Comprehensive Cancer Center
Holy Cross Hospital
|
|
Dr. Lieberfarb received a PhD in Pharmacology and an MD degree both from Stony Brook University in Stony Brook, NY. Prior to joining Holy Cross, he was a Clinical Fellow in Radiation Oncology at Harvard Medical School, where he also performed research on prostate cancer at the Dana Farber Cancer Institute in Boston, MA. He has received several academic honors and awards and is Board Certified in Radiation Oncology.
|
Nadia Ramdin, MD
Physician (Hematologist/Oncologist)
Bienes Comprehensive Cancer Center
Holy Cross Hospital
|
|
Dr. Ramdin received an MD degree from the University of Medicine and Dentistry-Robert Wood Johnson School of Medicine in Camden, New Jersey. She then received additional training and clinical practice in internal medicine and hematology/oncology at Brown University in Providence, Rhode Island. Dr. Ramdin has conducted research and published articles on the characteristics of and alternative treatments for cancer of the esophagus and pancreas.
|
Carl R. Tahn, MD, MPH
Physician (Hematologist/Oncologist)
Bienes Comprehensive Cancer Center
Holy Cross Hospital
|
|
Prior to joining Holy Cross in December, 2003, Dr. Tahn was an Assistant Professor of Hematology/Oncology at the Emory University College of Medicine in Atlanta, Georgia. Dr. Tahn earned his MD degree from George Washington University in Washington, D.C. and his MPH from the University of North Carolina, Chapel Hill. He is also a Major in the USAF (Inactive Reserves) and from 1994-1996 served as Chief of Internal Medicine at Laughlin USAFB in Del Rio, Texas. Presently, Dr. Tahn is participating in the conduct of four clinical trials of new cancer drugs.
|
Anne C. Washburn, MPH
Manager, Cancer Information Program
National Cancer Institute
Bethesda, MD
|
|
Ms. Washburn is Manager of the Communications Program in the NCI Office of Cancer Complementary and Alternative Medicine. Ms. Washburn's experience as a cancer patient educator includes being the Coordinator of the Cancer Patient Education and Support Program at the University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina for eight years. In addition, she served as Secretary of the NCI Cancer Patient Education Network and Chair of the Complementary and Alternative Medicine Taskforce. She earned her Master of Public Health and BS in Biology from the University of Tennessee-Knoxville.
|
Participating Organizations
- American Cancer Society
- Broward Ostomy Association
- First Presbyterian Church Support Group
- Gilda's Club
|
- Holy Cross Wellness Center
- Leukemia & Lymphoma Society
- New Voice Club
|
|
